Abt-418 Hydrochloride
$120 – $1290
ABT-418 is a nicotinic acetylcholine receptor (nAChR) agonist designed to enhance cholinergic signaling. It primarily targets α4β2 receptors, associated with cognitive functions like attention and memory. Initially studied for Alzheimer’s, ADHD, and schizophrenia, it showed cognitive benefits in preclinical models but faced challenges like limited therapeutic windows and side effects. Its pharmacological profile includes improved neurotransmission and potential neuroprotective effects, though development has not progressed significantly.
Product analysis:
NMR, LCMS (Click to open)
